Thriva is a proactive healthcare service, which offers at-home blood tests for a range of health markers such as Vitamin B12, Vitamin D, liver function, folate and iron. Consumers receive the testing kit in the post, and use the apparatus included to take a blood sample via a simple pin-prick.
The sample is sent to the lab in a return envelope; results are NHS-grade and available within 48 hours. Before being made available to the customer the results are reviewed by a team of qualified GPs who provide explanatory notes as well as clear personalised actions in a bespoke report – this is made available via an online portal.
|Date of investment||July 2019|
|Cost of investment||£1,330,000|
|% of ownership||5.2%|
|Latest valuation of Pembroke investment||£10,376,000|